Clinical trial

Alterations in the Human Microbiome With Commonly Used Topical Medications

Name
390406
Description
The global aim of this study is to investigate how the human microbiome changes from baseline with commonly used topical medications such as topical antifungals, low to mid potency topical steroids and emollients. The specific aims are as follows: 1. Investigate whether ketoconazole cream, a commonly used topical antifungal, causes alterations in the human skin microbiome with short-term use. 2. Investigate whether desonide 0.05 % ointment, a commonly used low potency topical steroid, alters the human microbiome with short-term use.
Trial arms
Trial start
2013-01-28
Estimated PCD
2026-09-28
Trial end
2026-09-28
Status
Recruiting
Phase
Early phase I
Treatment
Desonide 0.05%
Desonide 0.05% ointment topically twice daily for two weeks
Arms:
Desonide 0.05%
Ketoconazole 2%
Ketoconazole 2% cream topically twice daily for two weeks
Arms:
Ketoconazole 2%
Size
24
Primary endpoint
Number of bacteria per each species
2 weeks after initial dispensing
Eligibility criteria
The inclusion criteria: • Adults at least 18 years of age. The exclusion criteria: * Individuals with known chronically active skin diseases, including atopic dermatitis, psoriasis, seborrheic dermatitis, other autoimmune and inflammatory skin conditions. * Patients with a history of skin cancer, multiple nevi, or other isolated lesions will not be excluded. * Individuals who have used topical, intravenous, intramuscular, or oral antibiotics within the last 6 months * Individuals with known allergies to any of the study medications. * Individuals younger than 18 years of age. * Adults unable to consent * Non-English speaking individuals. Given the complexity in the instructions that subjects will need to follow for proper sample collection, we will not seek to recruit non-English speaking individuals for this pilot study. * Prisoners
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'The patient will be randomized to one of two groups, with one group receiving ketoconazole cream and the other receiving desonide ointment.', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'Investigator and subject will be blinded.', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 24, 'type': 'ESTIMATED'}}
Updated at
2024-01-23

1 organization

2 products

1 indication

Product
Desonide
Indication
Healthy